3/3/2025

Methylphenidate Transdermal System

Products Affected - Description

- Daytrana transdermal system, Noven, 10 mg/9 hours (1.1 mg/hr), patch, 30 count, NDC 68968-5552-03
- Daytrana transdermal system, Noven, 15 mg/9 hours (1.6 mg/hr), patch, 30 count, NDC 68968-5553-03
- Daytrana transdermal system, Noven, 20 mg/9 hours (2.2 mg/hr), patch, 30 count, NDC 68968-5554-03
- Daytrana transdermal system, Noven, 30 mg/9 hours (3.3 mg/hr), patch, 30 count, NDC 68968-5555-03
- Methylphenidate transdermal system, Mylan (Viatris), 10 mg/9 hours (1.1 mg/hr), patch, 30 count, NDC 00378-8260-93
- Methylphenidate transdermal system, Mylan (Viatris), 15 mg/9 hours (1.6 mg/hr), patch, 30 count, NDC 00378-8261-93
- Methylphenidate transdermal system, Mylan (Viatris), 20 mg/9 hours (2.2 mg/hr), patch, 30 count, NDC 00378-8262-93
- Methylphenidate transdermal system, Mylan (Viatris), 30 mg/9 hours (3.3 mg/hr), patch, 30 count, NDC 00378-8263-93
- Methylphenidate transdermal system, Padagis, 10 mg/9 hours (1.1 mg/hr), patch, 30 count, NDC 00574-2410-65
- Methylphenidate transdermal system, Padagis, 15 mg/9 hours (1.6 mg/hr), patch, 30 count, NDC 00574-2415-65
- Methylphenidate transdermal system, Padagis, 20 mg/9 hours (2.2 mg/hr), patch, 30 count, NDC 00574-2420-65
- Methylphenidate transdermal system, Padagis, 30 mg/9 hours (3.3 mg/hr), patch, 30 count, NDC 00574-2430-65

Reason for the Shortage

- Noven has Daytrana patches on shortage due a shortage of an active ingredient.
- Mylan (Viatris) has methylphenidate patches on shortage due a shortage of an active ingredient.
- Padagis has methylphenidate patches on shortage due a shortage of an active ingredient.

Available Products

- There is insufficient supply for usual ordering

Estimated Resupply Dates

- Mylan (Viatris) has all methylphenidate transdermal patches on back order and the company estimates a release date of late-May 2025.
- Noven has Daytrana 10 mg/9 hour and 30 mg/9 hour transdermal patches on back order and the company estimates a release date of April 2025 for the 10 mg/9 hour patches and July 2025 for the 30 mg/9 hour patches. The 15 mg/9 hour patches are expected to be in short supply starting in late-April and continue until mid-May 2025. The 20 mg/9 hour patches are expected to be in short supply starting in early-March 2025 and continue until July 2025.
- Padagis has methylphenidate transdermal patches on allocation.

Updated

Updated March 3, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created February 28, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.